LifeStance Health Group, Inc. Selling, General and Administrative Expense
LifeStance Health Group, Inc. (LFST) reported Selling, General and Administrative Expense of $108.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- LifeStance Health Group, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $108.14M, a 11.05% increase year-over-year.
- LifeStance Health Group, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $100.33M, a 6.25% increase year-over-year.
- LifeStance Health Group, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $94.78M, a 1.14% increase year-over-year.
- LifeStance Health Group, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $95.61M, a 12.13% increase year-over-year.
- LifeStance Health Group, Inc. selling, general and administrative expense for fiscal 2025 was $382.20M, a 5.27% increase from fiscal 2024.
- LifeStance Health Group, Inc. selling, general and administrative expense for fiscal 2024 was $363.06M, a 11.62% decline from fiscal 2023.
- LifeStance Health Group, Inc. selling, general and administrative expense for fiscal 2023 was $410.79M, a 8.68% increase from fiscal 2022.
- LifeStance Health Group, Inc. selling, general and administrative expense for fiscal 2022 was $377.99M, a 12.85% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 1 month | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 4 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108.14M 10-Q · filed 2026-08-06 | $208.47M 10-Q · filed 2026-08-06 | $303.25M derived: sum of 3 quarters · filed 2026-08-06 | $398.86M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $100.33M 10-Q · filed 2026-05-07 | $195.11M derived: sum of 2 quarters · filed 2026-05-07 | $290.72M derived: sum of 3 quarters · filed 2026-05-07 | $388.10M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $94.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $190.39M derived: sum of 2 quarters · filed 2026-02-25 | $287.77M derived: sum of 3 quarters · filed 2026-08-06 | $382.20M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $95.61M 10-Q · filed 2025-11-06 | $192.99M derived: sum of 2 quarters · filed 2026-08-06 | $287.42M 10-Q · filed 2025-11-06 | $381.13M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $97.38M 10-Q · filed 2026-08-06 | $191.81M 10-Q · filed 2026-08-06 | $285.51M derived: sum of 3 quarters · filed 2026-08-06 | $370.78M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $94.43M 10-Q · filed 2026-05-07 | $188.14M derived: sum of 2 quarters · filed 2026-05-07 | $273.41M derived: sum of 3 quarters · filed 2026-05-07 | $368.56M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $93.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $178.97M derived: sum of 2 quarters · filed 2026-02-25 | $274.13M derived: sum of 3 quarters · filed 2026-02-25 | $363.06M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $85.27M 10-Q · filed 2025-11-06 | $180.42M derived: sum of 2 quarters · filed 2025-11-06 | $269.36M 10-Q · filed 2025-11-06 | $362.72M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $95.15M 10-Q · filed 2025-08-07 | $184.09M 10-Q · filed 2025-08-07 | $277.45M derived: sum of 3 quarters · filed 2026-02-25 | $408.40M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $88.93M 10-Q · filed 2025-05-07 | $182.30M derived: sum of 2 quarters · filed 2026-02-25 | $313.25M derived: sum of 3 quarters · filed 2026-02-25 | $415.10M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $93.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $224.31M derived: sum of 2 quarters · filed 2026-02-25 | $326.17M derived: sum of 3 quarters · filed 2026-02-25 | $410.79M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $130.94M 10-Q · filed 2024-11-07 | $232.80M derived: sum of 2 quarters · filed 2024-11-07 | $317.43M 10-Q · filed 2024-11-07 | $407.24M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $101.85M 10-Q · filed 2024-08-08 | $186.48M 10-Q · filed 2024-08-08 | $276.30M derived: sum of 3 quarters · filed 2025-02-27 | $357.55M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $84.63M 10-Q · filed 2024-05-09 | $174.44M derived: sum of 2 quarters · filed 2025-02-27 | $255.69M derived: sum of 3 quarters · filed 2025-02-27 | $359.25M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $89.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $171.06M derived: sum of 2 quarters · filed 2025-02-27 | $274.62M derived: sum of 3 quarters · filed 2025-02-27 | $377.99M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $81.25M 10-Q · filed 2023-11-08 | $184.81M derived: sum of 2 quarters · filed 2023-11-08 | $288.18M 10-Q · filed 2023-11-08 | $440.83M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $103.56M 10-Q · filed 2023-08-09 | $206.93M 10-Q · filed 2023-08-09 | $359.58M derived: sum of 3 quarters · filed 2024-02-28 | $522.52M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $103.37M 10-Q · filed 2023-05-10 | $256.02M derived: sum of 2 quarters · filed 2024-02-28 | $418.96M derived: sum of 3 quarters · filed 2024-02-28 | $504.44M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $152.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $315.60M derived: sum of 2 quarters · filed 2024-02-28 | $401.07M derived: sum of 3 quarters · filed 2024-02-28 | $433.73M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $162.94M 10-Q · filed 2022-11-09 | $248.42M derived: sum of 2 quarters · filed 2022-11-09 | $281.07M 10-Q · filed 2022-11-09 | $304.74M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $85.48M 10-Q · filed 2022-08-10 | $118.13M 10-Q · filed 2022-08-10 | $141.79M derived: sum of 3 quarters · filed 2023-03-09 | $161.33M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $32.65M 10-Q · filed 2022-05-11 | $56.32M derived: sum of 2 quarters · filed 2023-03-09 | $75.85M derived: sum of 3 quarters · filed 2023-03-09 | $84.49M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $23.66M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $43.20M derived: sum of 2 quarters · filed 2023-03-09 | $51.84M 10-K · filed 2023-03-09 | |||
| 2020-09-30 | $19.53M 10-Q · filed 2021-11-10 | $28.18M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $8.64M 10-Q · filed 2021-08-12 | |||||
| 2020-05-14 | $7.19M 10-Q · filed 2021-08-12 | $20.85M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $41.06M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |